Since acquiring the rights to distribute the drug in 2007, pharmaceutical company Mylan has increased the price for EpiPens by approximately 400%. This has increased profits and performance for the company, but has also sparked immense backlash and accusations of price gouging. Examine Mylan’s decision to increase the price of the drug so drastically and the consequences of that decision.